Moderna MRNA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$2.82B+20.8% | -$3.56B+27.8% | -$4.93B-159% | $8.36B-31.5% | ||
| $215M+13.8% | $189M-69.6% | $621M+78.4% | $348M+50.0% | ||
| $483M+12.6% | $429M+40.7% | $305M+35.0% | $226M+59.2% | ||
| —— | —— | —— | $4.98B-63.4% | ||
| $192M-81.7% | $1.05B+48.7% | $707M+76.8% | $400M+40.8% | ||
| $1.99B— | —— | —— | —— | ||
| $600M— | $0— | $0— | —— | ||
| $594M+907% | $59M+104% | -$1.38B+60.1% | -$3.45B-295% | ||
| $668M— | —— | -$289M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
